Skip to main content
NCBI home page
Translational Psychiatry logoLink to Translational Psychiatry
. 2019 Oct 2;9:240. doi: 10.1038/s41398-019-0585-4

Correction to: The selective orexin-2 antagonist seltorexant (JNJ-42847922/MIN-202) shows antidepressant and sleep-promoting effects in patients with major depressive disorder

Kasper Recourt 1,2,✉,#, Peter de Boer 3,#, Rob Zuiker 1, Remy Luthringer 4, Justine Kent 5, Peter van der Ark 3, Ilse Van Hove 3, Joop van Gerven 1,2, Gabriel Jacobs 1,2, Luc van Nueten 3, Wayne Drevets 3
PMCID: PMC6775147  PMID: 31578318

Correction to: Translational Psychiatry

10.1038/s41398-019-0553-2 published online 3 September 2019

In the original Article, Tables two and three had formatting issues which affected their clarity. This has been corrected in the PDF and HTML versions of this Article.

Footnotes

The original article can be found online at 10.1038/s41398-019-0553-z.

These authors contributed equally: Kasper Recourt, Peter de Boer

Articles from Translational Psychiatry are provided here courtesy of Nature Publishing Group

RESOURCES